Opinion on Pharmaceuticals and Healthcare in Europe

Published within

« | ... | 110 | 111 | 112 | 113 | 114 | 115 | 116 | 117 | 118 | ... | » »|

Type Product title / description Pub Price
Expert View
Expert View

Power to the patients

Published By Datamonitor
29 Jun 2001
ResearchWire
ResearchWire

Schizophrenia: suffered by 1.3% of world population

Published By Datamonitor
27 Jun 2001
CommentWire
CommentWire

Schering AG: doubts over reassurances

Published By Datamonitor
27 Jun 2001
ResearchWire
ResearchWire

Stroke: two-fifths of UK emergency testing takes more than two hours

Published By Datamonitor
26 Jun 2001
ResearchWire
ResearchWire

Peripheral stents: only half of German procedures will be performed by radiologists in 2004

Published By Datamonitor
25 Jun 2001
CommentWire
CommentWire

Novartis: a small setback for Gleevec

Published By Datamonitor
25 Jun 2001
ResearchWire
ResearchWire

DTC pharmaceutical marketing: lifestyle and respiratory drugs are most advertised

Published By Datamonitor
22 Jun 2001
CommentWire
CommentWire

Migraines: the triptan market hots up

Published By Datamonitor
21 Jun 2001
ResearchWire
ResearchWire

Streptococcus pneumoniae vaccination: elderly patient potential of 7.4 million in 2007

Published By Datamonitor
21 Jun 2001
CommentWire
CommentWire

Novartis/BMS: it could be the end for Zelmac

Published By Datamonitor
20 Jun 2001

« | ... | 110 | 111 | 112 | 113 | 114 | 115 | 116 | 117 | 118 | ... | » »|

No help is available.